Does TENECTEPLASE Cause Ejection fraction decreased? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Ejection fraction decreased have been filed in association with TENECTEPLASE (TNKase). This represents 0.5% of all adverse event reports for TENECTEPLASE.
6
Reports of Ejection fraction decreased with TENECTEPLASE
0.5%
of all TENECTEPLASE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Ejection fraction decreased From TENECTEPLASE?
Of the 6 reports, 5 (83.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENECTEPLASE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TENECTEPLASE Cause?
Off label use (430)
No adverse event (313)
Cerebral haemorrhage (132)
Angioedema (112)
Haemorrhage intracranial (74)
Haemorrhage (71)
Drug ineffective (68)
Death (60)
Haemorrhagic transformation stroke (49)
Cerebrovascular accident (45)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which TENECTEPLASE Alternatives Have Lower Ejection fraction decreased Risk?
TENECTEPLASE vs TENELIGLIPTIN
TENECTEPLASE vs TENIPOSIDE
TENECTEPLASE vs TENOFOVIR
TENECTEPLASE vs TENOFOVIR ALAFENAMIDE
TENECTEPLASE vs TENOFOVIR DISOPROXIL